1. Home
  2. AS vs DGX Comparison

AS vs DGX Comparison

Compare AS & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AS
  • DGX
  • Stock Information
  • Founded
  • AS 1950
  • DGX 1967
  • Country
  • AS Finland
  • DGX United States
  • Employees
  • AS N/A
  • DGX N/A
  • Industry
  • AS
  • DGX Medical Specialities
  • Sector
  • AS
  • DGX Health Care
  • Exchange
  • AS NYSE
  • DGX Nasdaq
  • Market Cap
  • AS 21.2B
  • DGX 19.8B
  • IPO Year
  • AS 2024
  • DGX 1996
  • Fundamental
  • Price
  • AS $39.41
  • DGX $166.38
  • Analyst Decision
  • AS Strong Buy
  • DGX Buy
  • Analyst Count
  • AS 10
  • DGX 14
  • Target Price
  • AS $39.00
  • DGX $185.07
  • AVG Volume (30 Days)
  • AS 3.8M
  • DGX 897.3K
  • Earning Date
  • AS 08-19-2025
  • DGX 07-22-2025
  • Dividend Yield
  • AS N/A
  • DGX 1.90%
  • EPS Growth
  • AS N/A
  • DGX 6.41
  • EPS
  • AS 0.38
  • DGX 7.91
  • Revenue
  • AS $5,463,300,000.00
  • DGX $10,158,000,000.00
  • Revenue This Year
  • AS $20.48
  • DGX $10.38
  • Revenue Next Year
  • AS $13.72
  • DGX $4.03
  • P/E Ratio
  • AS $103.94
  • DGX $21.29
  • Revenue Growth
  • AS 20.27
  • DGX 9.38
  • 52 Week Low
  • AS $10.11
  • DGX $137.71
  • 52 Week High
  • AS $40.21
  • DGX $182.38
  • Technical
  • Relative Strength Index (RSI)
  • AS 63.14
  • DGX 29.54
  • Support Level
  • AS $37.51
  • DGX $171.29
  • Resistance Level
  • AS $39.96
  • DGX $174.47
  • Average True Range (ATR)
  • AS 1.22
  • DGX 3.04
  • MACD
  • AS -0.11
  • DGX -1.39
  • Stochastic Oscillator
  • AS 77.90
  • DGX 10.45

About AS AMER SPORTS INC

Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $5.2 billion in 2024. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2024, the firm generates 36% of its revenue from the Americas, 29% from Europe, the Middle East, and Africa, 25% from China, and 10% from Asia-Pacific, excluding China.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: